Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Observational Study to Assess the Durability and Safety of Collagenase Clostridium Histolyticum Injected With GRID Technique in Buttocks or Thigh Cellulite With Laxity in Adult Females
Conditions
Locations
3
United States
Endo Clinical Trial Site #2
Coral Gables, Florida, United States
Endo Clinical Trial Site #3
Metairie, Louisiana, United States
Endo Clinical Trial Site #1
New York, New York, United States
Start Date
January 25, 2022
Primary Completion Date
September 12, 2022
Completion Date
September 12, 2022
Last Updated
January 19, 2023
NCT05664581
NCT03782545
NCT05959681
NCT05885035
NCT05748678
NCT05624216
Lead Sponsor
Endo Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions